Guardian Pharmacy Services (NYSE:GRDN) Lowered to Hold Rating by Wall Street Zen

Wall Street Zen downgraded shares of Guardian Pharmacy Services (NYSE:GRDN) from a buy rating to a hold rating in a research note published on Saturday morning.

A number of other brokerages also recently weighed in on GRDN. Bank of America boosted their target price on shares of Guardian Pharmacy Services from $42.00 to $47.00 and gave the stock a “buy” rating in a research note on Wednesday, June 17th. Weiss Ratings cut shares of Guardian Pharmacy Services from a “hold (c+)” rating to a “hold (c)” rating in a research note on Monday, May 11th. Oppenheimer increased their price target on shares of Guardian Pharmacy Services from $38.00 to $43.00 and gave the company an “outperform” rating in a research note on Thursday, May 7th. Truist Financial raised their price target on shares of Guardian Pharmacy Services from $43.00 to $47.00 and gave the company a “buy” rating in a report on Wednesday, June 17th. Finally, Zacks Research cut shares of Guardian Pharmacy Services from a “strong-buy” rating to a “hold” rating in a research report on Monday, May 11th. Seven equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $42.83.

Guardian Pharmacy Services Stock Performance

Shares of NYSE:GRDN opened at $39.43 on Friday. Guardian Pharmacy Services has a twelve month low of $19.30 and a twelve month high of $44.00. The firm has a market cap of $1.96 billion, a PE ratio of 47.50, a price-to-earnings-growth ratio of 2.59 and a beta of 0.05. The business has a fifty day moving average of $40.72 and a 200-day moving average of $36.71.

Guardian Pharmacy Services (NYSE:GRDN) last issued its quarterly earnings results on Wednesday, May 6th. The company reported $0.29 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.24 by $0.05. The business had revenue of $336.60 million for the quarter, compared to the consensus estimate of $329.89 million. Guardian Pharmacy Services had a net margin of 3.64% and a return on equity of 30.72%. The firm’s quarterly revenue was up 2.2% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.22 EPS. On average, analysts anticipate that Guardian Pharmacy Services will post 1.18 EPS for the current fiscal year.

Institutional Trading of Guardian Pharmacy Services

A number of institutional investors and hedge funds have recently modified their holdings of GRDN. SG Americas Securities LLC grew its holdings in Guardian Pharmacy Services by 274.9% during the fourth quarter. SG Americas Securities LLC now owns 19,017 shares of the company’s stock valued at $572,000 after purchasing an additional 13,945 shares during the period. TimesSquare Capital Management LLC raised its holdings in Guardian Pharmacy Services by 21.9% in the fourth quarter. TimesSquare Capital Management LLC now owns 1,048,136 shares of the company’s stock worth $31,538,000 after purchasing an additional 187,963 shares during the period. Jennison Associates LLC acquired a new stake in Guardian Pharmacy Services in the fourth quarter worth $3,489,000. Globeflex Capital L P bought a new position in shares of Guardian Pharmacy Services during the fourth quarter worth $1,335,000. Finally, Bessemer Group Inc. bought a new position in shares of Guardian Pharmacy Services during the first quarter worth $2,962,000.

Guardian Pharmacy Services Company Profile

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes. The company’s Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; and GuardianShield Programs for LTCFs.